- Home
- IMAB vs EMX Comparison
IMAB vs EMX Comparison
Compare IMAB & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- EMX
- Stock Information
- Founded
- IMAB 2014
- EMX N/A
- Country
- IMAB United States
- EMX Canada
- Employees
- IMAB N/A
- EMX N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- EMX
- Sector
- IMAB Health Care
- EMX
- Exchange
- IMAB Nasdaq
- EMX Nasdaq
- Market Cap
- IMAB 384.6M
- EMX 338.0M
- IPO Year
- IMAB 2020
- EMX N/A
- Fundamental
- Price
- IMAB $3.69
- EMX $4.10
- Analyst Decision
- IMAB Strong Buy
- EMX Strong Buy
- Analyst Count
- IMAB 5
- EMX 2
- Target Price
- IMAB $6.80
- EMX $5.38
- AVG Volume (30 Days)
- IMAB 1.7M
- EMX 1.0M
- Earning Date
- IMAB 11-02-2025
- EMX 11-06-2025
- Dividend Yield
- IMAB N/A
- EMX N/A
- EPS Growth
- IMAB N/A
- EMX N/A
- EPS
- IMAB N/A
- EMX 0.04
- Revenue
- IMAB N/A
- EMX $29,864,000.00
- Revenue This Year
- IMAB N/A
- EMX $11.08
- Revenue Next Year
- IMAB N/A
- EMX $3.72
- P/E Ratio
- IMAB N/A
- EMX $89.99
- Revenue Growth
- IMAB N/A
- EMX N/A
- 52 Week Low
- IMAB $0.60
- EMX $1.65
- 52 Week High
- IMAB $5.90
- EMX $4.44
- Technical
- Relative Strength Index (RSI)
- IMAB 45.33
- EMX 65.33
- Support Level
- IMAB $3.20
- EMX $4.01
- Resistance Level
- IMAB $4.64
- EMX $4.44
- Average True Range (ATR)
- IMAB 0.41
- EMX 0.19
- MACD
- IMAB -0.17
- EMX 0.00
- Stochastic Oscillator
- IMAB 29.88
- EMX 66.67
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.